SCHEMBL24318138

SCHEMBL24318138

c1ccc(-c2nc(-c3ccc4c(c3)oc3cc5c(cc34)oc3ccccc35)nc(-c3cccc4c3sc3ccccc34)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 8/20 0.44
ALOX5 P09917 2/20 0.43
PIK3CD O00329 2/20 0.35
PIK3CB P42338 2/20 0.35
BRD4 O60885 1/20 0.34
PIK3CA P42336 1/20 0.34
MTOR P42345 1/20 0.34
PIK3CG P48736 1/20 0.34
KCNH2 Q12809 1/20 0.34
BRDT Q58F21 1/20 0.34
AHR P35869 2/20 0.33
PARP14 Q460N5 1/20 0.33
ESR2 Q92731 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
F9 P00740 1/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21890983 0.98 PRKDC (0.45) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL21784882 0.97 PRKDC (0.46) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL25645948 0.97 PRKDC (0.45) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL25947154 0.97 PRKDC (0.45) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL24264255 0.96 PRKDC (0.43) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL24264112 0.96 PRKDC (0.43) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL25019311 0.96 PRKDC (0.44) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL22135492 0.96 PRKDC (0.44) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL21784883 0.96 ALOX5 (0.43) PRKDCALOX5PIK3CDPIK3CBBRD4
SCHEMBL22330037 0.96 PRKDC (0.44) PRKDCALOX5PIK3CDPIK3CBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2022-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND ODC1, OTC, PKD1 PRKDC 2806/4885ALOX5 1698/4885PIK3CD 4023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.